SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-001934
Filing Date
2022-07-08
Accepted
2022-07-08 17:00:33
Documents
64
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kprx-20220331x10q.htm   iXBRL 10-Q 994031
2 EX-31.1 kprx-20220331xex31d1.htm EX-31.1 11269
3 EX-32.1 kprx-20220331xex32d1.htm EX-32.1 7567
  Complete submission text file 0001410578-22-001934.txt   4747121

Data Files

Seq Description Document Type Size
4 EX-101.SCH kprx-20220331.xsd EX-101.SCH 41828
5 EX-101.CAL kprx-20220331_cal.xml EX-101.CAL 39094
6 EX-101.DEF kprx-20220331_def.xml EX-101.DEF 172233
7 EX-101.LAB kprx-20220331_lab.xml EX-101.LAB 378164
8 EX-101.PRE kprx-20220331_pre.xml EX-101.PRE 285110
58 EXTRACTED XBRL INSTANCE DOCUMENT kprx-20220331x10q_htm.xml XML 687112
Mailing Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105
Business Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105 (781) 788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36672 | Film No.: 221075151
SIC: 2834 Pharmaceutical Preparations